UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (70) 70
life sciences & biomedicine (69) 69
humans (57) 57
male (34) 34
life sciences (31) 31
female (29) 29
middle aged (27) 27
adult (25) 25
hematology (24) 24
aged (19) 19
oncology (17) 17
abridged index medicus (15) 15
immunohistochemistry (15) 15
lymphoma (15) 15
adolescent (14) 14
aged, 80 and over (14) 14
lymphomas (14) 14
cancer (13) 13
mutation (12) 12
antineoplastic combined chemotherapy protocols - therapeutic use (11) 11
lymphoma, large b-cell, diffuse - drug therapy (11) 11
pathology (11) 11
young adult (11) 11
cyclophosphamide - administration & dosage (10) 10
human health and pathology (10) 10
prognosis (10) 10
[sdv]life sciences [q-bio] (9) 9
antineoplastic combined chemotherapy protocols - administration & dosage (9) 9
biopsy (9) 9
disease-free survival (9) 9
doxorubicin - administration & dosage (9) 9
hemic and lymphatic diseases (9) 9
immunology (9) 9
lymphoma, large b-cell, diffuse - genetics (9) 9
lymphoma, large b-cell, diffuse - mortality (9) 9
prednisone - administration & dosage (9) 9
research (9) 9
vincristine - administration & dosage (9) 9
[sdv.can]life sciences [q-bio]/cancer (8) 8
animals (8) 8
tumors (8) 8
b cells (7) 7
child (7) 7
genetic aspects (7) 7
medical research (7) 7
rituximab (7) 7
treatment outcome (7) 7
biomarkers, tumor - analysis (6) 6
child, preschool (6) 6
diffuse large b-cell lymphoma (6) 6
general & internal medicine (6) 6
kaplan-meier estimate (6) 6
medicine, experimental (6) 6
patients (6) 6
analysis (5) 5
antibodies, monoclonal, murine-derived - administration & dosage (5) 5
dermatology (5) 5
diagnosis (5) 5
genomics (5) 5
health aspects (5) 5
infant (5) 5
lymphocytes (5) 5
lymphoma, large b-cell, diffuse - diagnosis (5) 5
medicine, general & internal (5) 5
retrospective studies (5) 5
survival analysis (5) 5
survival rate (5) 5
transcriptome (5) 5
[ sdv.can ] life sciences [q-bio]/cancer (4) 4
[sdv.imm]life sciences [q-bio]/immunology (4) 4
biomarkers, tumor (4) 4
bone marrow (4) 4
case-control studies (4) 4
chemotherapy (4) 4
cohort studies (4) 4
combined modality therapy (4) 4
disease progression (4) 4
flow cytometry (4) 4
france (4) 4
gene expression profiling (4) 4
genes (4) 4
genetics & heredity (4) 4
genotype (4) 4
immune system diseases (4) 4
immunodeficiency (4) 4
immunophenotyping (4) 4
infant, newborn (4) 4
inflammation (4) 4
lymphoma, follicular - pathology (4) 4
medicine, research & experimental (4) 4
mesh: humans (4) 4
mice (4) 4
phenotype (4) 4
research & experimental medicine (4) 4
spleen (4) 4
thymic carcinoma (4) 4
thymoma (4) 4
[info.info-bi]computer science [cs]/bioinformatics [q-bio.qm] (3) 3
[sdv.mhep.hem]life sciences [q-bio]/human health and pathology/hematology (3) 3
age factors (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
American journal of hematology, ISSN 0361-8609, 09/2016, Volume 91, Issue 9, pp. 923 - 930
Journal Article
by Cerhan, James R and Berndt, Sonja I and Vijai, Joseph and Ghesquières, Hervé and McKay, James and Wang, Sophia S and Wang, Zhaoming and Yeager, Meredith and Conde, Lucia and de Bakker, Paul I W and Nieters, Alexandra and Cox, David and Burdett, Laurie and Monnereau, Alain and Flowers, Christopher R and De Roos, Anneclaire J and Brooks-Wilson, Angela R and Lan, Qing and Severi, Gianluca and Melbye, Mads and Gu, Jian and Jackson, Rebecca D and Kane, Eleanor and Teras, Lauren R and Purdue, Mark P and Vajdic, Claire M and Spinelli, John J and Giles, Graham G and Albanes, Demetrius and Kelly, Rachel S and Zucca, Mariagrazia and Bertrand, Kimberly A and Zeleniuch-Jacquotte, Anne and Lawrence, Charles and Hutchinson, Amy and Zhi, Degui and Habermann, Thomas M and Link, Brian K and Novak, Anne J and Dogan, Ahmet and Asmann, Yan W and Liebow, Mark and Thompson, Carrie A and Ansell, Stephen M and Witzig, Thomas E and Weiner, George J and Veron, Amelie S and Zelenika, Diana and Tilly, Hervé and Haioun, Corinne and Molina, Thierry Jo and Hjalgrim, Henrik and Glimelius, Bengt and Adami, Hans-Olov and Bracci, Paige M and Riby, Jacques and Smith, Martyn T and Holly, Elizabeth A and Cozen, Wendy and Hartge, Patricia and Morton, Lindsay M and Severson, Richard K and Tinker, Lesley F and North, Kari E and Becker, Nikolaus and Benavente, Yolanda and Boffetta, Paolo and Brennan, Paul and Foretova, Lenka and Maynadie, Marc and Staines, Anthony and Lightfoot, Tracy and Crouch, Simon and Smith, Alex and Roman, Eve and Diver, W Ryan and Offit, Kenneth and Zelenetz, Andrew and Klein, Robert J and Villano, Danylo J and Zheng, Tongzhang and Zhang, Yawei and Holford, Theodore R and Kricker, Anne and Turner, Jenny and Southey, Melissa C and Clavel, Jacqueline and Virtamo, Jarmo and Weinstein, Stephanie and Riboli, Elio and Vineis, Paolo and Kaaks, Rudolph and Trichopoulos, Dimitrios and Vermeulen, Roel C H and Boeing, Heiner and Tjonneland, Anne and Angelucci, Emanuele and Di Lollo, Simonetta and Rais, Marco and Birmann, Brenda M and ...
Nature genetics, ISSN 1546-1718, 09/2014, Volume 46, Issue 11, pp. 1233 - 1238
Diffuse large B cell lymphoma (DLBCL) is the most common lymphoma subtype and is clinically aggressive. To identify genetic susceptibility loci for DLBCL, we... 
Life Sciences & Biomedicine | Genetics & Heredity | Science & Technology | Quantitative trait loci | Genome-wide association studies | Genetic susceptibility | Lymphomas | Genetic aspects | B cells | Research | Health aspects | Risk factors | Studies | Confidence intervals | Genealogy | Genes | Genomics | Genomes | Chromosomes | Cancer | Meta-analysis | Index Medicus
Journal Article
PloS one, ISSN 1932-6203, 09/2008, Volume 3, Issue 9, pp. e3262 - e3262
...Author(s): Eric Jeziorski 1, Brigitte Senechal 1, Thierry Jo Molina 1,2, Francis Devez 2, Marianne Leruez-Ville 3, Patrice Morand 4, Christophe Glorion 3... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Antigens, CD1 - biosynthesis | Herpesvirus 6, Human - metabolism | Cytomegalovirus - metabolism | Histiocytosis, Langerhans-Cell - diagnosis | Humans | Child, Preschool | Herpesviridae Infections - complications | Infant | Histiocytosis, Langerhans-Cell - virology | Herpesviridae Infections - diagnosis | Case-Control Studies | Histiocytosis, Langerhans-Cell - epidemiology | Antigens, CD20 - biosynthesis | Adolescent | CD79 Antigens - biosynthesis | Adult | Herpesvirus 4, Human - metabolism | Child | Immunosuppressive Agents - pharmacology | Cohort Studies | Herpesviridae Infections - epidemiology | Histiocytosis, Langerhans-Cell - complications | Infection | Viral antibodies | Virus diseases | Medical research | Dendritic cells | Analysis | Medicine, Experimental | Antibodies | Epstein-Barr virus | B cells | Histiocytosis | Epidemiology | Granuloma | Disease | Laboratories | Copy number | Pathogenesis | Viruses | Infections | Genomes | Biology | Antibody response | Lymphocytes | Bone marrow | Children | Localization | Age | Deoxyribonucleic acid--DNA | Cytomegalovirus | Blood & organ donations | Patients | Lymphoma | Virology | Polymerase chain reaction | Studies | Immunosuppression | Lymphocytes B | Herpes viruses | Langerhans cells | CD20 antigen | Index Medicus | Deoxyribonucleic acid | DNA | Lymphomas
Journal Article
The Lancet (British edition), ISSN 0140-6736, 11/2011, Volume 378, Issue 9806, pp. 1858 - 1867
Summary Background The outcome of diffuse large B-cell lymphoma has been substantially improved by the addition of the anti-CD20 monoclonal antibody rituximab... 
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Cyclophosphamide - adverse effects | Dose-Response Relationship, Drug | Young Adult | Vindesine - adverse effects | Adult | Female | Prednisolone | Doxorubicin - administration & dosage | Severity of Illness Index | Prednisone - administration & dosage | Lymphoma, Large B-Cell, Diffuse - drug therapy | Prednisone - adverse effects | Drug Administration Schedule | Risk Assessment | Rituximab | Treatment Outcome | Bleomycin - administration & dosage | Bleomycin - adverse effects | Vincristine | Lymphoma, Large B-Cell, Diffuse - mortality | Disease-Free Survival | Lymphoma, Large B-Cell, Diffuse - diagnosis | Maximum Tolerated Dose | Adolescent | Survival Analysis | Vindesine - administration & dosage | Doxorubicin - adverse effects | Chemotherapy | Physiological aspects | Lymphomas | B cells | Drug therapy | Methods | Cancer | Dehydrogenases | Toxicity | Population studies | Doxorubicin | Evidence-based medicine | Hepatitis | Randomization | Bleomycin | Motivation | Drug dosages | Neutropenia | Cell survival | Hematology | Prednisone | Survival | Patients | Lymphoma | Cyclophosphamide | Lymphocytes B | Monoclonal antibodies | CD20 antigen | Tumors | B-cell lymphoma | Clinical trials | Public speaking | Grants | Clinical medicine | Index Medicus | Abridged Index Medicus | Side effects | lymphoma | survival | International standardization | chemotherapy
Journal Article
The lancet oncology, ISSN 1470-2045, 05/2013, Volume 14, Issue 6, pp. 525 - 533
Journal Article
Journal of allergy and clinical immunology, ISSN 0091-6749, 07/2016, Volume 138, Issue 1, pp. 210 - 218.e9
Background Activated phosphoinositide 3-kinase δ syndrome (APDS) 2 (p110δ-activating mutations causing senescent T cells, lymphadenopathy, and immunodeficiency... 
Allergy and Immunology | and immunodeficiency | p110δ-activating mutations causing senescent T cells | hyper-IgM | adenopathy | p110δ | activated phosphoinositide 3-kinase δ syndrome | p85α | antibody deficiency | immunodeficiency | lymphadenopathy | phosphoinositide 3-kinase | Primary immunodeficiency | Class I Phosphatidylinositol 3-Kinases/genetics | RNA Splice Sites | Gene Frequency | Humans | Middle Aged | Immunologic Deficiency Syndromes/diagnosis | Child, Preschool | Genotype | Male | Young Adult | CD8-Positive T-Lymphocytes/immunology | Phenotype | T-Lymphocyte Subsets/immunology | Biopsy | Adolescent | Alleles | Adult | Female | Mutation | Child | Cohort Studies | Allergy | Immunology | Life Sciences & Biomedicine | Science & Technology | T-Lymphocyte Subsets - immunology | Class I Phosphatidylinositol 3-Kinases - genetics | Immunologic Deficiency Syndromes - etiology | Immunologic Deficiency Syndromes - mortality | CD8-Positive T-Lymphocytes - metabolism | Immunologic Deficiency Syndromes - diagnosis | T-Lymphocyte Subsets - metabolism | CD8-Positive T-Lymphocytes - immunology | Index Medicus | Abridged Index Medicus | Life Sciences | Human health and pathology | Economics and Finance | Psychology | Santé publique et épidémiologie | Humanities and Social Sciences | Psychiatrics and mental health
Journal Article